nimodipine has been researched along with Drug Hypersensitivity in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Drug Hypersensitivity: Immunologically mediated adverse reactions to medicinal substances used legally or illegally.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nucera, E | 1 |
| Schavino, D | 1 |
| Roncallo, C | 1 |
| de Pasquale, T | 1 |
| Buonomo, A | 1 |
| Pollastrini, E | 1 |
| Patriarca, G | 1 |
1 other study available for nimodipine and Drug Hypersensitivity
| Article | Year |
|---|---|
Delayed-type allergy to oral nimodipine.
Topics: Administration, Oral; Aged; Allergens; Drug Eruptions; Drug Hypersensitivity; Follow-Up Studies; Hum | 2002 |